Guided Therapeutics, Inc.

    Jurisdiction
    United States
    LEI
    549300A0UBF5OC8O7M54
    ISIN
    US40171F5017 (GTHP)
    Sectors
    1. Healthcare
    2. Medical - Devices

    Scores

    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    4 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    2 / 7

    Profile

    Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. Read full profile

    Fundamentals

    Net revenue
    €100.65K
    Gross margin
    65.3%
    EBIT
    -€1.94M
    EBIT margin
    -1,924.6%
    Net income
    -€2.35M
    Net margin
    -2,333.9%

    Statement period: - (published )

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    No dividend payouts

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    Grujic Alan N/A +152K $0.00 +$0.00
    Imhoff John E N/A +167K $0.18 +$30.00K
    JAMES MICHAEL C N/A +28K $0.18 +$5.00K

    Earnings Calls

    Add to watchlist

    Notifications